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Key Points: 
 
 Circular RNAs are hugely enriched in platelets compared to nucleated cell types  
 Lack of enrichment in megakaryocte progenitors implicates degradation of platelet linear 
RNAs 
 
 
 
 
ABSTRACT 
 
In platelets, splicing and translation occur in the absence of a nucleus. However, the integrity 
and stability of mRNAs derived from megakaryocyte progenitor cells remain poorly quantified on a 
transcriptome-wide level. As circular RNAs (circRNAs) are resistant to degradation by exonucleases, 
their abundance relative to linear RNAs can be used as a surrogate marker for mRNA stability in the 
absence of transcription. Here we show that circRNAs are enriched in human platelets 17-188 fold 
relative to nucleated tissues, and 14-26 fold relative to samples digested with RNAseR to selectively 
remove linear RNA. We compare RNAseq read depths inside and outside circRNAs to provide in silico 
evidence of transcript circularity, show that exons within circRNAs are enriched on average 12.7X in 
platelets relative to nucleated tissues, and identify 3162 genes significantly enriched for circRNAs, 
including some where all RNAseq reads appear to be derived from circular molecules. We also 
confirm that this is a feature of other anucleate cells through transcriptome sequencing of mature 
erythrocytes, demonstrate that circRNAs are not enriched in cultured megakaryocytes, and that 
linear RNAs decay more rapidly than circRNAs in platelet preparations. Collectively, these results 
suggest that circulating platelets have lost over 90% of their progenitor mRNAs, and that translation 
in platelets occurrs against the backdrop of a highly degraded transcriptome. Finally, we find that 
transcripts previously classified as products of reverse transcriptase template switching are both 
enriched in platelets and resistant to decay, countering the recent suggestion that up to 50% of 
rearranged RNAs are artefacts.  
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INTRODUCTION 
Platelets are small, anucleate, circulating blood cells derived from large polyploid 
megakaryocyte progenitors [1]. They are vital for basic functions such as hemostasis, wound healing 
and angiogenesis [2]. Unlike anucleate erythrocytes which have a lifespan of ~4 months and have 
greatly reduced ribosome numbers [3], platelets are short lived (~8-11 days [4]), translationally 
competent [5], and some genes have been shown to undergo cytoplasmic splicing upon platelet 
activation [6, 7]. Consistent with these observations, recent RNAseq analyses have defined a 
complex transcriptome [8-11]. However, some transcripts believed to contribute to platelet function 
are expressed at very low levels in RNAseq data [11], and attempts to integrate transcriptome and 
proteome data have given conflicting results [12-15]. In the absence of nuclear transcription, RNAs 
within platelets are assumed to degrade over time. Although the abundance of individual mRNAs 
have been shown to fall in platelets stored at ambient temperatures [16], the stability and integrity 
of mRNAs within circulating platelets is poorly characterised at the transcriptome level. However, 
this is highly relevant to functional inferences drawn from RNAseq data [9, 11, 15, 17, 18]. 
Transcripts with rearranged exon order are now known to be very common in eukaryotic 
organisms, and are characterised at the sequence level by “back-splice” exon junctions inconsistent 
with the underlying genomic DNA [19-24]. Evidence for linear and polyadenylated structures has 
been presented [20, 25, 26], but it is now clear that most are both circular (circRNAs) and 
cytoplasmic [21-23]. Recent experiments using minigene expression constructs have established that 
intronic repeats flanking rearranged exons can promote circularisation, and that circRNAs primarily 
utilise canonical splice sites [27-30] and can be regulated by RNA binding proteins [29, 31]. Although 
two non-coding cytoplasmic circRNAs have been shown to act as miRNA sponges [22, 26], and 
circRNAs with retained introns (Exon-Intron or EIcircRNAs) can enhance transcription of their 
parental genes through interaction with U1 snRNP and RNA PolII [32], the vast majority of circRNAs 
consist of exons from protein encoding genes and have no known function [22, 33].  
Circular RNAs are resistant to attack by exonucleases involved in the regulation of mRNA [34] 
and resistance to one, RNAseR, has been used to define them [23, 35]. Furthermore, blocking of 
transcription leads to an increase in circRNA levels relative to linear [23]. This differential stability 
raises the possibility that the abundance of circRNAs relative to linear forms could provide insight 
into the platelet transcriptome. Here, we analyse the circRNA population of platelets, and compare 
it to populations in nucleated cells, enucleated erythrocytes, and cells where linear RNA has been 
digested with RNAseR. We show that circRNAs are highly enriched in both platelets and erythrocytes 
relative to nucleated tissues, and confirm this experimentally using qPCR. We then analyse platelet 
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RNAseq read counts within exons which contribute to circRNAs and identify over 3000 genes where 
circRNAs are significantly enriched relative to nucleated cell types, including some genes where only 
circRNAs producing exons are represented within the RNAseq data. We also use qPCR to establish 
that circRNAs are not enriched in cultured magakaryocytes and that, over time, the levels of linear 
RNAs fall relative to circRNAs in platelet preparations. Our results suggest that over 90% of mRNAs 
have been lost from circulating platelets, and have potentially important implications for both 
platelet biology and our understanding of circRNAs. 
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MATERIAL AND METHODS 
Datasets used 
In silico analyses (RNAseq, circRNA abundance and decay analysis) were performed on 
RNAseq data generated during the study and on 36 publicly available datasets. 24 of these were 
ribosomal RNA depleted total RNA fractions sequenced on the Illumina platform [11, 23, 27, 36, 37], 
2 polyA+ selected samples sequenced on the  Ilumina platform [11, 38], and 10 non-ribosomal RNA 
depleted total RNA sequenced on the SOLiD platform [15]. For details, see Supplementary Methods 
and Supplementary Table S1. 
 
Erythrocyte RNAseq 
Ribosome depleted RNAseq of total RNA from Red Blood cells was performed by AROS 
Applied Biotechnology (Aarhus, Denmark) using the TruSeq RiboZero Stranded mRNA LT kit 
(Illumina). The library was sequenced using a paired-end 100 base pair protocol on a Hi Seq 2000 
(Illumina), all according to manufacturer’s recommendations (see Supplementary Methods).   
 
circRNA identification 
Identification of back-splice exon junctions was performed using PTESFinder Pipeline v. 1 
(http://sourceforge.net/projects/ptesfinder-v1/). This identifies all RNAseq reads which map in 
inverted order but the same orientation to the same RefSeq entry, generates models of these 
junctions, and re-maps all reads under analysis to the models. It then eliminates potential false 
positives through removal of reads which do not utilise known exon junctions, and reads which map 
equally well or better to the genomic or transcriptome reference (see Supplementary Methods and 
Supplementary Table S2 for details). 
 
Biological samples: origin and preparation 
RNAs from human solid tissues were obtained from Biochain (Amsbio, UK). Red Blood Cells 
were obtained from the Scottish National Blood Transfusion Service (SNBTS) in accordance with the 
terms of the standard donor consent form and information, and with approval of the SNBTS Sample 
Governance Committee. Cord blood was obtained after informed consent under a protocol 
approved by the National Research Ethics Service (Cambridgeshire 4 Research Ethics Committee ref. 
No. 07/MRES/44).  Whole blood samples were collected from healthy volunteers with approval from 
Newcastle University’s Faculty of Medical Sciences Ethics Committee. Platelets and platelet rich 
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plasma (PRP) were isolated according to a protocol which utilises a platelet inhibitory cocktail [39]. 
Isolation of peripheral blood mononuclear cells (PBMCs) and red blood cells (RBCs) was performed 
using Histopaque-1.077 density gradient (Sigma-Aldrich) according to manufacturer’s instructions. 
Megakaryoctes were cultured and isolated according to the protocol of Tijssen et al. [40]. For further 
details see Supplementary Methods. 
 
RNA isolation and cDNA generation 
RNA was isolated using Trizol (Lifetechnologies) and treated with DNase I (Promega) 
according to manufacturer’s instructions. RNA quantitation was performed using the NanoDrop ND-
1000 spectrophotometer (Thermo Scientific) and quality was assessed using the Agilent 2100 
Bioanalyser (Agilent Technologies). cDNA was synthesised using high capacity cDNA kits (Applied 
Biosystem), random hexamers, and Moloney murine leukaemia virus (MMLV) unless stated 
otherwise.  
 
Real time PCR 
Real time PCR was performed using Taqman mastermix (Lifetechnologies) as described 
previously [20]. Where linear and circular structures from the same gene were analysed, a common 
probe was used. Primers and assay efficiencies are given in Supplementary Table S1. Transcript 
expression was normalised using the ∆CT method relative to the geometric mean of 4 housekeeping 
genes (GAPDH, PPIA, TUBB, GUSB) analysed using TaqMan gene expression assays (Applied 
Biosystems). Circular transcripts were also normalised against the linear transcript from the same 
gene where appropriate. Reactions were performed in 10 µl volumes in 384 plates using 
QuantStudio 7 Flex (Applied Biosystems) with the following cycling parameters: 2 minutes at 50oC, 
10 minutes at 95 oC, followed by 40 cycles of 15 seconds at 95 oC and 60 oC for 1 minute. The 
Wilcoxon rank sum test was used to compare levels of circRNA v linear RNA across multiple 
structures (analysis of paired –Ct values), and to compare linear v circRNA expression ratios 
between conditions or sample types (analysis of –Ct values across all structures).  
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RESULTS 
Platelets are highly enriched for circRNAs 
We first identified 3 publicly available RNAseq datasets from human platelets [9, 11, 15],  
one of which had a sequence read length long enough for the identification of back-splice junctions 
within circRNAs, and included samples processed to retain unpolyadenylated RNAs (Array express i.d. 
E-MTAB-1846; 100bp Illumina ribosome depleted total RNAseq from 3 individuals, and polyA+ 
RNAseq from 1 individual [11]). Analysis of the 3 total RNAseq samples using a back-splice junction 
discovery pipeline (PTESFinder see Methods) identified 33829 distinct structures consistent with 
circRNAs (Supplementary Figure 1 and Supplementary Table S3), approximately 4-5X more than 
reported for Fibroblasts [23] and ~15X more than reported for leukocytes and HEK293 cells [22] in 
libraries of comparable size. Furthermore, it identified 62%-64% of structures previously identified 
within RNAseq data from cell lines digested with RNAseR to selectively remove linear transcripts [23, 
27], consistent with them being primarily derived from circRNAs. Despite the large number identified, 
the majority are not platelet specific, as 24632 (~73%) were also present in one or more of 15 
ENCODE RNAseq datasets previously mined by Salzman et al. (2013) (Supplementary Figure S1).  
Having identified an apparent abundance of circRNAs in platelets, we then used PTESFinder 
to identify circRNAs within other publicly available datasets generated using ribosome depleted total 
RNAseq and sequenced using the Illumina platform. These consisted of a panel of 12 human tissues 
[37], ENCODE cell lines [41], and cell lines treated with RNAseR to selectively remove linear RNAs [23, 
27]. To enable comparison with a distinct anucleate cell type, we also generated >120 million 100bp 
paired-end Illumina RNAseq reads from total RNA extracted from leukocyte depleted red blood cells 
(RBCs, GEO record # GSE69192, see methods). These data, summarised in Figure 1 and presented in 
Supplementary Table S3, show that 17-188 times more circRNA (back-splice) reads are present in 
platelets than in human nucleated tissues (7579-11138 circRNA junction reads per million reads 
versus 59-447), and 14-26 times more circRNA reads than samples treated with RNAseR (427-463 
junction reads per million reads). However, the numbers of circRNA structures and circRNA 
producing genes identified in anucleate cells are comparable to the numbers in RNAseR digested 
samples. In addition, the mean numbers of circRNA structures per circRNA producing gene are larger 
in anucleate and RNAseR digested samples than in others, with two of the three platelet samples 
averaging over 5 structures per gene, compared to 1-2 for nucleated tissues and cell lines.  
We also analysed the platelet polyA+ sample from E-MTAB-1846 and identified 841 circRNA 
structures from 453 genes. However, their nucleotide composition was found to be significantly 
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enriched for A residues relative to structures present only in platelet total RNA (Chi squared = 12317 
p<2.2e-16, Supplementary Table S4). As this suggests that these structures are non-polyadenylated 
circRNA transcripts rich in A nucleotides, they were not analysed further. 
More than 600 platelet genes generate over 20 distinct circRNAs. 
To illustrate the variation in circRNA distributions, the numbers of circRNA structures 
identified per gene are displayed for 4 samples in Figure 2A. Strikingly, both platelets and the 
fibroblasts digested with RNAseR (which increases circRNA levels by degrading liner RNAs) have large 
numbers of genes generating >15 distinct circRNA structures. For example, the platelet sample 
has >600 genes each with >20 different circRNAs. Furthermore, as shown in Table 1, individual 
structures in anucleate samples are supported by much larger back-splice junction read counts than 
in nucleated tissues (p=2.7x10-4 anucleate v nucleated counts, Wicoxon rank sum test). All 3 platelet 
samples have over 1000 structures supported by over 100 reads, in sharp contrast to undigested 
nucleated samples. As an example of the diversity of structures and read support within platelets, 
the 49 inferred circRNA structures identified within the XPO1 gene are shown in Figure 2B, with 
supporting read counts ranging from 1 (E8-E5 and E16-E7) to 4045 (E4-E2). It is noteworthy that all 
21 of the internal exons of this gene are encompassed by one or more circRNA (illustrating that most 
exons within some genes can contribute to circRNAs), and that only 11 of these structures were 
identified previously in RNAseR digested H9 RNA [27]. 
Real Time PCR confirmation of high circRNA transcript levels in anucleate cells.  
 To experimentally confirm the enrichment of circRNAs in both anucleate cell types, we used 
qPCR to assess the relative levels of linear and circRNAs. We first assayed expression of the 
mononucleocyte expressed CD45 antigen (PTPRC), and performed cell counts to confirm that 
nucleated white blood cells were being efficiently removed during platelet isolation (Supplementary 
Figure S2 and Supplementary Methods). As a precaution against Reverse Transcriptase (RT) specific 
artefacts which have been reported [42] we also checked that all circRNAs being analysed could be 
amplified using templates generated with both AMV and MMLV RTs (Supplementary Figure S3). We 
then analysed the abundance of two known circRNA structures from MAN1A2 (E4-E2 and E5-E2 [22]) 
relative to the canonical MAN1A2 transcript, two structured from  PHC3 (a gene expressed in 
platelets for which assays were already available [20]), and an additional 7 abundant circRNAs 
together with their associated linear RNAs (see Supplementary Table S1). For each, paired assays 
with a common probe were used (Figure 3A).  
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Both of the MAN1A2 circRNA junctions are much more abundant in platelets and RBCs than 
the linear mRNA (Figure 3B). However, they are less abundant than the linear transcripts in virtually 
all other nucleated tissues analysed. This is consistent with both the RNAseq data and previous 
analyses of nucleated tissues [20, 22]. The other 9 circRNAs are also all expressed at higher levels in 
platelets and RBCs than their corresponding linear structures (Figure 3C), with circRNAs from 
SMARCA5, UBXN7 and PNN registering ~6-10 cycles before their corresponding linear RNAs, 
suggesting that they are ~50-1000 fold more abundant. In contrast, all are expressed in nucleated 
cells at an equivalent or lower level than their linear counterparts. Collectively, the difference in 
relative expression levels of linear and circRNAs between anucleate and nucleated tissues is highly 
significant (p=2.7x10-12 Wilcoxon rank sum test). 
Finally, the impact of RNAseR digestion upon expression was also assessed (Figure 3D). 
Digestion increases the expression of all back splice junctions relative to the canonical linear 
junctions in each cell type analysed (p=7.8x10-3 Wilcoxon paired rank sum test, mock digest v 
RNAseR digest), although the MAN1A2 E5-E2 back-splice shows only a marginal increase in the 
platelet sample (Figure 3D). This confirms that these structures include circRNAs. However, the 
impact of RNAseR digestion upon the relative levels of linear and circRNAs is more pronounced in 
peripheral blood mononuclear cells (PBMC) and in HEK293 cells than in either anucleate sample 
(p<0.02, Wilcoxon paired rank sum test for all pairwise nucleated v anucleated comparisons).  
For some genes, only reads from circRNA producing exons are detected in platelets 
The abundance of individual circRNAs relative to mRNAs from the same loci has previously 
been estimated in silico by comparing back-splice junction read counts to flanking canonical junction 
counts [20, 21, 43]. However, because most circRNA producing genes generate multiple overlapping 
structures (e.g. Figure 2B and Supplementary Table S3), the canonical junctions flanking one circRNA 
are often present within others. We therefore performed a transcriptome-wide analysis where we 
compared the average read count within exons which contribute to circRNAs, to the read count in 
exons which do not (see Supplementary Table S5). For each gene we calculated the RPKM across all 
exons internal to all known circRNA structures (RPKMI), and the RPKM across exons external to all 
known circRNAs (RPKME). The former is a measure of both linear and circRNA expression, the latter 
linear only. Box and whisker plots showing RPKMI/RPKME ratios for all circRNA producing genes in all 
samples are presented in Figure 4A. The ratios from individual genes extend over 6-8 orders of 
magnitude for each sample, but what is most striking is that the median RPKMI/RPKME ratios of the 
anucleate samples are approximately 12 times higher than nucleated tissues, and approximately 5 
times higher than samples digested with RNAseR (Figure 4A). The distribution of RNAseq reads 
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within these genes therefore reflects the pattern of circRNA structures inferred from exon-junction 
read counts alone (Figures 1 and 2), and provides further evidence that the back-splice junctions are 
predominantly derived from circRNAs.  
To identify genes significantly enriched for circRNAs in platelets, for each gene we then 
estimated the contribution of circRNA producing exons to total transcription by calculating 
RPKMI/(RPKMI + RPKME) ratios, and compared ratios in the platelet samples to ratios in the 12 
nucleated tissues using the Wilcoxon rank test (p-value = 0.05, Benjamin and Hochberg false 
discovery rate = 0.01). Out of 8041 circRNA producing genes analysed, 3162 showed significantly 
enriched transcription from circRNA producing exons in platelets (Supplementary Table S5).  When 
the ratios from all genes with an average RPKM >1 in platelets are plotted (Figure 4B), it can be seen 
that for the vast majority of enriched genes the contribution of circRNA exons to total transcription 
is >0.6 in nucleated tissues, but >0.8 in platelets. Furthermore, transcription from circRNA producing 
exons for 457 genes exceeds an average of 99% in the platelet samples, and for 15 genes it is 100% 
in all 3 samples (Supplementary Table S5) indicating that all reads detected are from circRNA 
producing exons. As this assay is not dependent on exon junction counts, which require long 
sequence reads for accurate detection, we were also able to apply it to one of the SOLiD platelet 
RNAseq datasets [15], and confirmed the presence of similar patterns of circRNA exon enrichment 
(e.g. Supplementary Figure 4, and Supplementary Data File 1).  
Reads from circRNA producing exons are enriched in platelets by up to 3000 fold  
To estimate the magnitude of circRNA exon enrichment for each gene in platelets relative to 
other tissues, we further analysed genes with an average RPKMI >1 by normalising their mean 
platelet RPKMI/RPKME ratio against the mean RPKMI/RPKME ratio from all 12 nucleated samples. The 
average enrichment was 12.7X for all genes, and 22X for the 3162 significantly enriched genes, with 
the highest enrichment being 3590X for TMEM181 (Figure 4C and Supplementary Table S5). To 
illustrate these extreme levels of enrichment, RNAseq read counts and circRNA junction read counts 
for 4 enriched genes from a single platelet sample are shown in Figure 5. The vast majority of 
platelet RNAseq reads from PNN (enrichment 2189X) map to exons 7 and 8 which correspond to the 
most abundant circRNA (Figure 5A); the majority of reads from SLC20A2 (enrichment 152X) map to 
the abundant circRNAs involving exons 3-5 (Figure 5B); all reads from POMT1 (enrichment 127X) 
map to exons within its only circRNA (E4-E3 Figure 5C), while for PHC3 (enrichment 240X), the reads 
map largely to the abundant E6-E5 and E7-E5 structures (Figure 5D).  
11 
 
Although all of our in silico analyses point to enrichment specifically in anucleate cells, no 
total RNAseq data has been generated from megakaryocytes, the direct progenitors of these cells. 
For all genes with assays available, we therefore also analysed the relative levels of linear and 
circRNAs in megakaryocytes cultured from cord blood. These were harvested after 10 days, 
when >70% of cells were positive for CD41 and CD42 (See Supplementary Methods). The results, 
presented in Figure 5 panels E and F, establish that megakaryocytes have very similar relative levels 
of linear and circRNA compared to other nucleated cell types (Fig 2B); all circRNAs are expressed at a 
much lower relative to linear RNAs than in platelets (p=1.4x10-6 Wilcoxon paired rank sum test 
across all structures). This is consistent with circRNA enrichment occurring after platelet formation.  
 
Confirmation of differential decay of linear and circRNAs in platelet preparations  
Human mRNAs are subject to a wide variety of decay pathways [44], and exhibit extensive 
variation in decay rates [45-47]. To investigate decay in platelets, we first correlated the change in 
transcript abundance between megakaryocyte PolyA+ RNA and platelet PolyA+ RNA with published 
estimates of mRNA half-life [45]. This identified a weak but highly significant correlation, despite the 
difference in cell types between datasets analysed, with short half-life genes showing a more 
pronounced reduction in transcript abundance (r=0.17, p=3.35e-44, Figure 6A). This is consistent 
with a transcriptome-wide role for mRNA decay in platelet expression levels.  
To experimentally investigate differential decay, we then used Real Time PCR to analyse 
changes in linear and circRNA abundance in platelet rich plasma (PRP) over time (see Methods). 
Consistent with previous analysis [16] initial experiments suggested that all transcript levels 
remained stable at 4oC, but that degradation of mRNA could be detected when incubation 
temperature was elevated to 37oC (data not shown). We therefore assayed the relative abundance 
of linear and circRNAs in PRP from 3 individuals, before and after incubation at 37oC for 72 and 96 
hours (Figure 6B). The levels of all 4 housekeeping genes were reduced by incubation, with raw CT 
values increasing by 4-6 cycles (Figure 6B top left panel). Reduction was also observed when genes 
which are highly abundant in platelets were analysed (Supplementary Figure S5). Normalisation of 
the linear transcripts from circRNA producing genes against the housekeeping pool (Figure 6B, top 
right panel) suggests that there are differences in decay rates between genes, with UBXN7, PNN and 
MAN1A2 transcripts being enriched relative to control housekeeping RNAs. Strikingly, however,  
circRNAs analysed show significant enrichment (2-6 fold, Figure 6B, lower panel,) relative to linear 
RNAs after incubation (p<2x10-3 for both day 0 v 72 hours and day 0 v 96 hours, Wilcoxon rank sum 
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test across all structures). This confirms that linear structures are decaying more rapidly than 
circRNAs in platelets.  
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DISCUSSION 
Platelets are anucleate yet retain the machinery required for splicing and translation, and there 
is extensive evidence that specific genes are translated in activated platelets [5-7, 48-50]. As a result, 
recent platelet transcriptome analyses have generated considerable interest [8, 17, 18]. However, 
here we have shown that the platelet transcriptome is significantly enriched for circRNAs as assayed 
using back-splice junction counts, real-time PCR, and an RNAseq comparative read depth approach. 
Back-spice reads are enriched 17-188 fold relative to nucleated tissues, and over 3000 genes have a 
statistically significant enrichment of reads from circRNA producing exons. Furthermore, for some 
genes only RNAseq reads derived from circRNA producing exons are detected within platelet 
samples, highlighting the impact this enrichment will have upon RNAseq based estimates of 
expression levels. We have also established that circRNAs are not enriched in cultured 
megakaryocytes compared to other nucleated cell types.  
While we cannot formally rule out the possibility that some circRNA enrichment occurs at the 
transcriptional level late in megakaryocyte maturation, collectively our results suggest that 
enrichment occurs specifically in platelets, after the loss of nuclear influence. The similarly high 
levels of enrichment observed in anucleate RBCs are consistent with this, while the observed 
reduction of linear RNAs relative to circRNAs in platelets incubated at 37oC confirms that differential 
decay occurs. The overall level of enrichment of RNAseq reads from circRNA producing exons is 
consistent with platelet mRNA levels being at least 90% lower than within nucleated tissues (average 
enrichment 12.7X for genes with RPKMI>1). Although this is a rough and indirect estimate, it is likely 
to be conservative as it assumes no degradation of circRNAs. Furthermore, the fraction of 
translatable RNAs is likely to be even lower, as our analysis has only considered RNA abundance, not 
structural integrity. This is consistent with the  suggestion that platelet lifespan may be determined 
by translational competence [51]. 
Degradation has been assumed to be a feature of the platelet transcriptome based purely on 
their anucleate nature [51]. Mitochondrially encoded genes are among the most highly expressed 
[52], levels of individual mRNAs have been shown to fall when platelet preparations are incubated at 
ambient temperature [16], and there is some evidence that translation is reduced in aged platelets 
relative to the whole population [51]. Consideration of mRNA half lives alone would suggest that 
mRNA degradation is likely to be substantial, unless platelet specific mechanisms exist to counteract 
it. If we assume the average age of circulating platelets is 4 days (and that functional separation from 
the nucleus occurs at day 0), then mRNA half-lives [45] would predict gene specific reductions in 
expression ranging from 1.2X to 720X, with a mean reduction of 14X. Our estimate of 12.7X based on 
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RNAseq read counts is broadly consistent with this, despite the fact that RPKMI/(RPKMI + RPKME) 
ratios will vary between genes due to a variety of factors which are unrelated to circularity, including 
differential isoform abundance, overlapping UTRs between neighbouring genes, and the reduction in 
RNAseq read coverage close to transcript termini. 
Extensive mRNA degradation provides a simple explanation for conflicting reports concerning 
the correlation between the platelet transcriptome and proteome [12, 13, 15, 53], and for the 
presence of proteins in platelets without corresponding mRNAs [15, 50]. It can also explain why 
many genes which have been shown to be spliced and/or translated in platelets, such as Tissue 
Factor (F3) [7, 54], IL1B [55], SLC23A2 [56], FGA, FGB, FGG, ALB [57], and BCL3 [58], are present at 
very low levels or not at all in some RNAseq datasets [10, 11]. Collectively, our results indicate that 
translation in platelets occurs against the backdrop of a rapidly degrading transcriptome, that 
platelets will differ in their translational potential in an age dependent manner, and that RNAseq 
analyses targeted towards intact species which are capped [15, 18] or polysome bound will be 
required to analyse translational potential in these cells effectively. 
CircRNAs have been identified from RNAseq data by the back-splice exon junctions they contain, 
and such junctions have been taken prima facie as evidence of circularity [24, 33, 59, 60]. Our exon-
partitioned analysis of read-depth provides additional in silico evidence that the structures which 
contain these junctions are primarily circular, as trans-splicing of independent linear pre-mRNA [20, 
42] would affect exons both up and downstream of the back-spliced exons. The higher number of 
circRNAs identified in platelets compared to RNAseR digested total RNA is, however, surprising as 
RNAseR selectively digests linear transcripts. This suggests that RNAseR removal of linear RNAs in 
vitro may be a relatively crude tool when compared to decay in vivo. This could be due both to 
limitations of enzyme specificity, and the lability of RNA post extraction. The significant enrichment 
of A nucleotides within back-splice transcripts present within platelet polyA+ RNA is also noteworthy 
as it means their presence within oligodT selected RNA fractions does not necessarily imply 
polyadenylation, as has been suggested previously [20, 42]. This may adversely affect the accuracy of 
RNAseq based mRNA expression estimates of the genes involved. 
It has recently been suggested that up to 50% of RNAs with back splice exon junction are reverse 
transcriptase artefacts. This was extrapolated from an analysis of 13 back-splice RNAs where the 
only 6 RNAs which could be independently validated were those which could be amplified using both 
AMV and MMLV reverse transcriptases [42]. However, among the 7 RNAs which could not be 
validated, 4 were intragenic back-splice structures and all are present within platelets: The back-
splice counts of 3 (PHC3 E6-E5, CNTLN E5-E3, RERE E3-E3) are enriched relative to other tissues 
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(~1000X, ~100X, ~4X), and read counts in exons between each back-splice are also enriched (240X, 
~30X, 500X) indicative of circRNAs. Furthermore, the PHC3 E6-E5 structure degrades more slowly 
than linear RNA, is resistant to RNAseR digestion [23], and in our hands can be amplified from cDNA 
generated using either MMLV or AMV (Supplementary Figure S3). These diverse lines of evidence 
suggest that there may not be a straightforward relationship between RT-specificity and artefacts as 
previously suggested [42]. 
Finally, cellular levels of circRNAs are known to be low in proliferating and neoplastic human 
cells [43, 60] but to increase during differentiation of ES cells [61] and during Drosophila 
development [62], suggesting that they may be a biomarker for ageing. Among nucleated tissues 
they are highest in both human and Drosophila neural tissues [43, 62] and are particularly enriched 
in synapses [43]. They are also enriched in exosomes [63]. These observations, together with the 
presence of miRNA binding sites within circRNAs [62], and the dynamic expression patterns of some 
[43], implies that they may be of functional importance. CircRNA levels can be modulated by intronic 
homology [23, 27, 28], and splicing factors such as Quaking [31] and Muscleblind [29]. However, our 
qPCR analysis of transcripts in MKs suggests that the extreme enrichment in platelets reported here 
is not due to modulation at the pre-mRNA level within progenitor cells. With no transcription in 
platelets it can, therefore, only be accounted for by differential degradation/decay. The differential 
degradation and very high levels of enrichment reported here suggests that, even if the relative 
levels of linear and circRNAs from each gene remain constant at the level of transcription, subtle 
changes in expression level, rates of mRNA export, changes in the cell cycle [60], changes in nuclear 
and cytoplasmic volumes, and distance from the nucleus could all alter relative abundance over time. 
Many reported differences in linear and circRNA levels could, therefore, be due to their stability 
alone. 
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LEGENDS TO TABLES AND FIGURES 
Table 1. circRNA read support for structures and their frequency in all samples. For each sample, 
the number of distinct circRNA structures supported by over 10, 100 and 1000 circRNA (back-splice) 
reads are shown, together with the number of circRNA reads per million reads (K/M). D – Digested 
with RNAseR, U – Undigested, matched sample. 
Figure 1. CircRNAs in human tissues. The number of circRNAs (structure counts), junction reads 
(read counts), circRNA producing genes (gene counts), mean number of circRNA transcripts per 
circRNA producing genes, and RNAseq library sizes (read counts) are shown. Samples are presented 
as 4 groups: nucleated tissues, nucleated cell lines, nucleated cell lines digested with RNAseR, and 
anucleated cell types. The number of back spice reads is significantly higher in anucleate samples 
(platelets and RBCs) than all others (p=2.7x104 Wilcoxon Rank Sum test, figures adjusted for library 
size) All data was processed using PTESFinder using publicy available datasets, with the exception of 
the data from RBC (see Methods and Supplementary Tables S2 for details of datasets and S3 for 
details of structures). 
Figure 2. CircRNA structures per gene. A. Histograms showing circRNA numbers per gene 
established using PTESFinder for RBCs (this study), Platelets [11], Fibroblasts and Fibroblasts 
digested with RNAseR [23]. B. Schematic diagram showing XPO1 gene intron/exon organisation 
together with the read counts and inferred structure of all back-splice junctions identified within the 
3 platelet samples. Inferred structures assume that all internal Refseq exons are present within the 
structure defined by each back-splice. Read counts for the 11 structures identified previously within 
RNAseR digested H9 ES cells [27] are highlighted in red. 
Figure 3. Confirmation of circRNA abundance and resistance to RNAseR. A. Schema of qPCR assays 
using an E5-E2 circRNA as an example. All assays use a common reporter probe, and utilise either an 
exon downstream of the circRNA to assay linear expression (probe in donor exon), or an exon 
upstream (probe in acceptor exon). B. Left panel - Expression levels (-∆CT values) of linear (Ex1-2) 
and circular (Ex5-2, and Ex4-2) MAN1A2 transcripts relative to housekeeping pool. Right panel - 
Expression levels of circRNAs relative to linear RNAs from the same loci normalised to housekeeping 
pool (-∆∆CT values). C. Expression of 9 circRNAs relative to linear forms from the same loci, 
normalised to housekeeping pool (-∆∆CT values). D. Change in CT values of circRNAs relative to 
linear forms from the same loci in RNAse digested RNAs, normalised to mock digested RNAs (-∆∆CT 
values). Templates, circRNAs and linear forms assayed are indicated. 
Figure 4. Differential read depth defines genes with significant circRNA enrichment in platelets. A. 
Box and Whisker plots showing the Ratio of RPKM from circRNA producing exons (RPKMI) to RPKM 
from exons which do not produce circRNAs (RPKME) for all genes in each sample. The median, upper 
and lower quartiles are shown, with outliers as solid circles. B. The proportion of reads from circRNA 
producing exons averaged across all nucleated samples (Y axis) and platelets (X axis). C. Fold 
enrichment of reads from circRNA producing exons in platelets relative to nucleated tissues. All 
genes with an average RPKMI >1 in platelets and expressed in 8 or more nucleated tissues are shown. 
Blue – genes significantly enriched in platelets. Red – genes not significantly enriched in platelets. 
The datapoints corresponding to the 5 most enriched genes are indicated. The slope x=y is shown as 
a dashed line. 
Figure 5. circRNA enrichment occurs in platelets but not megakaryocytes. A-D. adapted UCSC 
screen shots for 4 genes which extreme circRNA enrichment in platelets. Each panel shows RNAseq 
read abundance in a single Platelet total RNA sample (F1), together with the position and abundance 
of back-splice exon junctions in the same sample. The intron-exon structure is shown below, with 
exons known to contribute to circRNAs shown in red. CircRNA structures present in the sample 
together with back-splice frequencies are also shown (for PHC3, only structures with 10 or more 
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back-splice reads are shown). Above each panel, the gene name, cytogenetic location, coding strand, 
and scale in kilobases, is indicated. E-F. Expression levels of circRNAs relative to linear RNAs from the 
same loci in platelets and cultured megakaryocytes, normalised to housekeeping pool (-∆∆CT values).  
 
Figure 6. Degradation of platelet RNA. A. Correlation of the change in gene expression between 
megakaryocte polyA+ RNA and platelet polyA+ RNA (Y axis), and mRNA half life estimates (X axis). 
Distributions of both are shown as histograms on each axis. B. qPCR analysis of differential decay of 
linear and circRNAs in platelets following incubation at 37oc for 0, 72 and 96 hours. Data from 3 
biological replicates are shown. Top left panel - Expression levels of housekeeping genes (CT values); 
Top right panel - Expression levels of linear structures from 5 circRNA producing genes relative to 
housekeeping pool (-∆CT values); Bottom panel - Expression levels of 7 circRNAs relative to linear 
transcripts from the same loci, both normalised to housekeeping pool (-∆∆CT values).  
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